Marius Geanta, Cosmina Cioroboiu, Bianca Cucos, Adriana Boata
{"title":"Romania's Pioneering Law: Establishing the Right to Personalized Medicine.","authors":"Marius Geanta, Cosmina Cioroboiu, Bianca Cucos, Adriana Boata","doi":"10.1089/omi.2024.0039","DOIUrl":null,"url":null,"abstract":"<p><p>This analysis and commentary discuss Romania's landmark law, the first globally, acknowledging the right of citizens and patients to personalized medicine. Initiated following the EU Council's 2015 policy on personalized medicine, the law is a result of intersectoral collaborative efforts led by the Centre for Innovation in Medicine in Romania using a quadruple (later evolved to penta) helix model involving academia, public, private, and civil society sectors. Promulgated on May 24, 2023, the law legally entitles patients to personalized health care and in ways informed by individual genetic and phenotypic consideration. The law mandates informed consent for medical interventions and ensures data protection in accordance with the General Data Protection Regulation. We suggest that this pioneering legislation paves the way for integrating personalized medicine into Romania's health care system, shaping clinical practice, research, and health policy. In all, it marks a significant step in redefining health care delivery, emphasizing individualized treatment and the political determinants of personalized medicine, and setting a precedent for future health care innovations worldwide.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/omi.2024.0039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/14 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
This analysis and commentary discuss Romania's landmark law, the first globally, acknowledging the right of citizens and patients to personalized medicine. Initiated following the EU Council's 2015 policy on personalized medicine, the law is a result of intersectoral collaborative efforts led by the Centre for Innovation in Medicine in Romania using a quadruple (later evolved to penta) helix model involving academia, public, private, and civil society sectors. Promulgated on May 24, 2023, the law legally entitles patients to personalized health care and in ways informed by individual genetic and phenotypic consideration. The law mandates informed consent for medical interventions and ensures data protection in accordance with the General Data Protection Regulation. We suggest that this pioneering legislation paves the way for integrating personalized medicine into Romania's health care system, shaping clinical practice, research, and health policy. In all, it marks a significant step in redefining health care delivery, emphasizing individualized treatment and the political determinants of personalized medicine, and setting a precedent for future health care innovations worldwide.
本分析和评论讨论了罗马尼亚具有里程碑意义的法律,这是全球首部承认公民和患者享有个性化医疗权利的法律。该法是在欧盟理事会 2015 年发布个性化医疗政策后启动的,是罗马尼亚医学创新中心(Centre for Innovation in Medicine in Romania)领导的跨部门合作努力的成果,采用了四螺旋(后演变为五螺旋)模式,涉及学术界、公共部门、私营部门和民间社会。该法于 2023 年 5 月 24 日颁布,从法律上赋予了患者获得个性化医疗服务的权利,并以个人基因和表型考虑为依据。该法规定,医疗干预必须获得知情同意,并根据《通用数据保护条例》确保数据保护。我们认为,这项开创性的立法为将个性化医疗纳入罗马尼亚的医疗保健系统、影响临床实践、研究和卫生政策铺平了道路。总之,它标志着在重新定义医疗保健服务、强调个性化治疗和个性化医疗的政治决定因素方面迈出了重要一步,并为全球未来的医疗保健创新开创了先例。